(Q73176793)

English

Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound

scientific article published on 01 December 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Differentiation of coronary smooth muscle cells to a cell cycle-arrested hypertrophic growth status by a synthetic non-toxic heparin-mimicking compound (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

A Schmidt

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

I Vlodavsky

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

W Völker

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

E Buddecke

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

147

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

387-397

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

The heparin-binding (fibroblast) growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Are we mortgaging the medical profession?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

The pathogenesis of atherosclerosis: a perspective for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Cell-associated proteoheparan sulfate from bovine arterial smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Effects of collagen matrix on proliferation and differentiation of vascular smooth muscle cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty: pathologic observations in 20 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Antiproliferative activity to vascular smooth muscle cells and receptor binding of heparin-mimicking polyaromatic anionic compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Isolation of nuclei from liver and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

A new staining method (OTO) for enhancing contrast of lipid--containing membranes and droplets in osmium tetroxide--fixed tissue with osmiophilic thiocarbohydrazide(TCH)

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Mitogen-activated protein kinase pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

How MAP kinases are regulated

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Determination of in Vivo Phosphorylation Sites in Protein Kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Protein kinase C is regulated in vivo by three functionally distinct phosphorylations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Suppression by heparin of smooth muscle cell proliferation in injured arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Heparin selectively inhibits a protein kinase C-dependent mechanism of cell cycle progression in calf aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Protein kinase C alpha activates RAF-1 by direct phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Cell division arrest induced by phorbol ester in CHO cells overexpressing protein kinase C-delta subspecies

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Overexpression of protein kinase C beta 1 in the SW480 colon cancer cell line causes growth suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Endothelin, vascular hypertrophy, and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Inhibitory effect of heparin on serotonin-induced hyperplasia and hypertrophy of smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

In vitro and in vivo effects of UP 269-6, a new potent orally active nonpeptide angiotensin II receptor antagonist, on vascular smooth muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Chronic systemic treatment with epidermal growth factor induces smooth muscle cell hyperplasia and hypertrophy in the urinary tract of mature Goettingen minipigs

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Aortic changes in experimental renal failure: hyperplasia or hypertrophy of smooth muscle cells?

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Hypertrophy and hyperplasia of smooth muscle cells of small intramyocardial arteries in spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Role of basic fibroblast growth factor in vascular lesion formation

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900209-9

7 January 2021

Identifiers

10.1016/S0021-9150(99)00209-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10559525%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73176793&oldid=2095114333"